Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review

Despite a good initial response to chemotherapy, the majority of patients with epithelial ovarian cancer will eventually recur and die of their disease. The introduction of targeted therapies to traditional chemotherapy regimens has done little to improve overall survival in women with ovarian cance...

Full description

Bibliographic Details
Main Authors: Haller J. Smith, J. Michael Straughn, Donald J. Buchsbaum, Rebecca C. Arend
Format: Article
Language:English
Published: Elsevier 2017-05-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578917300292